These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 22566812)
1. A four-step model for the IL-6 amplifier, a regulator of chronic inflammations in tissue-specific MHC class II-associated autoimmune diseases. Murakami M; Hirano T Front Immunol; 2011; 2():22. PubMed ID: 22566812 [TBL] [Abstract][Full Text] [Related]
2. Local microbleeding facilitates IL-6- and IL-17-dependent arthritis in the absence of tissue antigen recognition by activated T cells. Murakami M; Okuyama Y; Ogura H; Asano S; Arima Y; Tsuruoka M; Harada M; Kanamoto M; Sawa Y; Iwakura Y; Takatsu K; Kamimura D; Hirano T J Exp Med; 2011 Jan; 208(1):103-14. PubMed ID: 21220456 [TBL] [Abstract][Full Text] [Related]
3. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection. Coutinho A; Caramalho I; Seixas E; Demengeot J Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475 [TBL] [Abstract][Full Text] [Related]
4. Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir. Hirano T Proc Jpn Acad Ser B Phys Biol Sci; 2010; 86(7):717-30. PubMed ID: 20689230 [TBL] [Abstract][Full Text] [Related]
6. The role of T-cell-mediated mechanisms in virus infections of the nervous system. Dörries R Curr Top Microbiol Immunol; 2001; 253():219-45. PubMed ID: 11417137 [TBL] [Abstract][Full Text] [Related]
7. Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells. Sawa S; Kamimura D; Jin GH; Morikawa H; Kamon H; Nishihara M; Ishihara K; Murakami M; Hirano T J Exp Med; 2006 Jun; 203(6):1459-70. PubMed ID: 16717113 [TBL] [Abstract][Full Text] [Related]
8. Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis. Waldburger JM; Palmer G; Seemayer C; Lamacchia C; Finckh A; Christofilopoulos P; Baeten D; Reith W; Gabay C Arthritis Rheum; 2011 Nov; 63(11):3354-63. PubMed ID: 21739421 [TBL] [Abstract][Full Text] [Related]
9. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens. Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344 [TBL] [Abstract][Full Text] [Related]
10. Effects of C2ta genetic polymorphisms on MHC class II expression and autoimmune diseases. Yau AC; Piehl F; Olsson T; Holmdahl R Immunology; 2017 Apr; 150(4):408-417. PubMed ID: 27861821 [TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells. Ratcliffe NR; Wegmann KW; Zhao RW; Hickey WF J Autoimmun; 2000 Nov; 15(3):369-79. PubMed ID: 11040077 [TBL] [Abstract][Full Text] [Related]
12. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex. Lustgarten J; Waks T; Eshhar Z Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555 [TBL] [Abstract][Full Text] [Related]
13. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663 [TBL] [Abstract][Full Text] [Related]
14. MHC Class II Presentation in Autoimmunity. Ishina IA; Zakharova MY; Kurbatskaia IN; Mamedov AE; Belogurov AA; Gabibov AG Cells; 2023 Jan; 12(2):. PubMed ID: 36672249 [TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8. Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392 [TBL] [Abstract][Full Text] [Related]
17. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production. McMenamin C; Holt PG J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390 [TBL] [Abstract][Full Text] [Related]
18. Induction of tolerance against the arthritogenic antigen with type-II collagen peptide-linked soluble MHC class II molecules. Park YK; Jung S; Park SH BMB Rep; 2016 Jun; 49(6):331-6. PubMed ID: 26779996 [TBL] [Abstract][Full Text] [Related]
19. Some cloned murine CD4+ T cells recognize H-2Ld class I MHC determinants directly. Other cloned CD4+ T cells recognize H-2Ld class I MHC determinants in the context of class II MHC molecules. McKisic MD; Sant AJ; Fitch FW J Immunol; 1991 Nov; 147(9):2868-74. PubMed ID: 1717578 [TBL] [Abstract][Full Text] [Related]
20. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus. Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]